6 withdrawn, 2 completed, 1 unknown. 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Withdrawn 6, Completed 2, Unknown 1 |
Follow EMS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain Canadá, Canadá placebo, Dipyrone - Pain, Chronic | Phase 2 | Withdrawn | EMS | 2026-09-01 | 2023-09-08 | |
| Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain TIRADENTES ASSOCIATION, DIPYRONE, TRAMADOL - Acute Pain | Phase 2 | Withdrawn | EMS | 2023-03-01 | 2023-09-08 | |
| Efficacy and Safety of Escócia Association in the Treatment of Acute Pain Escócia association, Placebo Ketorolac, Placebo Scopolamine - Acute Pain | Phase 2 | Withdrawn | EMS | 2023-02-01 | 2023-09-08 | |
| Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. Venus 20 + 0,064, Venus 20 + 1, Venus 20 + 4 - Vulvovaginal Candidiasis | Phase 2 | Withdrawn | EMS | 2022-07-01 | 2022-08-10 | |
| A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia. WAS123, Aripiprazole (Fixed dose) - Schizophenia Disorder | Phase 2 | Completed | EMS | 121 | 2022-05-10 | 2026-09-25 |
| Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis Florence 30 μg/mL, Florence 60 μg/mL, Florence 90 μg/mL - Eosinophilic Esophagitis | Phase 2 | Unknown | EMS | 116 | 2021-04-19 | 2023-02-24 |
| Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia Hipnos 3, Hipnos 5, Hipnos 5 Placebo - Insomnia | Phase 2 | Withdrawn | EMS | 2021-01-01 | 2021-04-01 | |
| Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification SATURNO II association, Vigadexa® - Ocular Inflammation, Cataract | Phase 2 | Completed | EMS | 118 | 2020-02-27 | 2022-03-07 |
| Efficacy of Fixed-doses of Antihypertensive and Statin Drugs Viena II 160/10, Viena II 190/10, Viena II 160/12 - Hypertension, Dyslipidemia | Phase 2 | Withdrawn | EMS | 2019-01-01 | 2019-10-16 |
Acute Pain (2) · Agnosia (1) · Candidiasis, Vulvovaginal (1) · Cataract (1) · Chronic Pain (1) · Dyslipidemias (1) · Eosinophilic Esophagitis (1) · Hypertension (1) · Schizophrenia (1) · Sleep Initiation and Maintenance Disorders (1)
Dipyrone (2) · Tramadol (2) · Aripiprazole (1) · Ketorolac Tromethamine (1) · Moxifloxacin (1) · Scopolamine (1) · butoconazole (1)
Brazil (3)
Cassiano Berto (1)